10X Genomics Inc (TXG) — Financial Flexibility Index
10X Genomics Inc (TXG) has a Financial Flexibility Index of 0.18x as of September 2025. Free cash flow of $43.90 Million (operating CF $43.21 Million minus capex $687.00K) represents 0% of total liabilities ($241.03 Million). Also explore how fast is 10X Genomics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
10X Genomics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for 10X Genomics Inc across 8 annual periods. Check 10X Genomics Inc (TXG) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for 10X Genomics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for 10X Genomics Inc. For the full company profile including market capitalisation, see TXG company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.09x | $19.06 Million | $6.66 Million | $208.50 Million | ▼ -40.3% |
| 2023 | 0.15x | $34.33 Million | $-15.20 Million | $224.10 Million | ▼ -65.1% |
| 2022 | 0.44x | $98.06 Million | $-33.61 Million | $223.24 Million | ▲ +10.6% |
| 2021 | 0.40x | $79.91 Million | $-21.37 Million | $201.26 Million | ▲ +142.1% |
| 2020 | -0.94x | $-179.50 Million | $-217.90 Million | $190.27 Million | ▼ -326.5% |
| 2019 | 0.42x | $77.39 Million | $34.63 Million | $185.84 Million | ▲ +305.7% |
| 2018 | -0.20x | $-69.70 Million | $-76.41 Million | $344.30 Million | ▼ -448.5% |
| 2017 | -0.04x | $-6.94 Million | $-10.70 Million | $188.12 Million | — |